FNY Investment Advisers’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$623K Buy
2023
Q4
Sell
2023
Q3
$272K Buy
2022
Q4
Sell
2022
Q3
$3.98M Buy
2021
Q1
Sell
2020
Q4
$1.32M Buy
2020
Q3
$1.27M Buy
2020
Q2
$412K Buy
2020
Q1
$301K Buy
2019
Q4
Sell
2019
Q3
$258K Buy